High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli

Biotechnology and Bioengineering

Volumn 95, Issue 4, 2006, Pages 684-691

  Newman, Jack D ^a,f   Marshall, Jessica ^a   Chang, Michelle ^a   Nowroozi, Farnaz ^b   Paradise, Eric ^a   Pitera, Douglas ^a   Newman, Karyn L ^c   Keasling, Jay D ^a,b,c,d,e  

^a University of California   (United States)

^b University of California at Berkeley   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e Berkeley   (United States)

^f Amyris Biotechnologies   (United States)

Author keywords

Amorphadiene; Escherichia coli; Fermentation; Heterologous pathway; Terpene

Indexed keywords

BIOREACTORS; BIOSYNTHESIS; DRUG PRODUCTS; ESCHERICHIA COLI; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM;

AMORPHADIENE; HETEROLOGOUS PATHWAY; OFF-GAS; TERPENE;

OLEFINS;

ALKADIENE; AMORPHA 4,11 DIENE; ANTIMALARIAL AGENT; DODECANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOREACTOR; BIOSYNTHESIS; CULTURE MEDIUM; ESCHERICHIA COLI; FERMENTATION; METABOLIC ENGINEERING; METHODOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN ISOLATION; VOLATILIZATION;

ANTIMALARIALS; ARTEMISININS; BIOREACTORS; ESCHERICHIA COLI; FERMENTATION; GASES; HALF-LIFE; SESQUITERPENES; TERPENES; VOLATILIZATION;

AMORPHA; ESCHERICHIA COLI;

EID: 33750557880     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21017     Document Type: Article

References (16)

1. Amann E, Ochs B, Abel KJ. 1988, Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene 69(2):301-315.
2. Carter OA, Peters RJ, Croteau R 2003. Monoterpene biosynthesis pathway construction in Escherichia coli. Phytochemistry 64(2):425-433.
3. Collins LD, Daugulis AJ. 1999. Benzene/toluene/p-xylene degradation. Part I. Solvent selection and toluene degradation in a two-phase partitioning bioreactor. Appl Microbiol Biotechnol 52(3):354-359.
4. Daugulis AJ. 1997. Partitioning bioreactors. Curr Opin Biotechnol 8(2): 169-174.
5. Daugulis AJ, Janikowski TB. 2002. Scale-up performance of a partitioning bioreactor for the degradation of polyaromatic hydrocarbons by Sphingomonas aromaticivorans. Biotechnol Lett 24:591-594.
6. Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177(14):4121-4130.
7. Janikowski TB, Velicogna D, Punt M, Daugulis AJ. 2002. Use of a two-phase partitioning bioreactor for degrading polycyclic aromatic hydrocarbons by a Sphingomonas sp. Appl Microbiol Biotechnol 59(2-3):368-376.
8. Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, Roop RM 2nd, Peterson KM. 1995. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166(1):175-176.
9. Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. 2003. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 21(7):796-802.
10. Ngo KS, Wong WT, Brown GD. 1999. Muurolane sesquiterpenes from Illicium tsangii. J Nat Prod 62(4):549-553.
11. Peiru S, Menzella HG, Rodriguez E, Carney J, Gramajo H. 2005. Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl Environ Microbiol 71(5):2539-2547.
12. Pfeifer BA, Admiraal SJ, Gramajo H, Cane D, Khosla C. 2001. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291(5509):1790-1792.
13. Picaud S, Olofsson L, Brodelius M, Brodelius PE. 2005. Expression, purification, and characterization of recombinant amorpha-4,11-diene synthase from Artemisia annua L. Arch Biochem Biophys 436(2):215-226.
14. Ramos JL, Duque E, Gallegos MT, Godoy P, Ramos-Gonzalez MI, Rojas A, Teran W, Segura A. 2002. Mechanisms of solvent tolerance in gram-negative bacteria. Annu Rev Microbiol 56:743-768.
15. Schmidt FR. 2004. Recombinant expression systems in the pharmaceutical industry. Appl Microbiol Biotechnol 65(4):363-372.
16. Watts KT, Mijts BN, Schmidt-Dannert C. 2005. Current and emerging approaches for natural product biosynthesis in microbial cells. Adv Synth Catal 347:927-940.